Enovis Revenue 2010-2024 | ENOV
Enovis revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Enovis Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,707 |
| 2022 | $1,563 |
| 2021 | $1,426 |
| 2020 | $1,121 |
| 2019 | $3,327 |
| 2018 | $2,193 |
| 2017 | $1,937 |
| 2016 | $3,186 |
| 2015 | $3,434 |
| 2014 | $4,624 |
| 2013 | $4,207 |
| 2012 | $3,914 |
| 2011 | $693 |
| 2010 | $542 |
| 2009 | $525 |
| Enovis Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $516 |
| 2023-12-31 | $455 |
| 2023-09-30 | $418 |
| 2023-06-30 | $429 |
| 2023-03-31 | $406 |
| 2022-12-31 | $409 |
| 2022-09-30 | $384 |
| 2022-06-30 | $395 |
| 2022-03-31 | $375 |
| 2021-12-31 | $-169 |
| 2021-09-30 | $360 |
| 2021-06-30 | $356 |
| 2021-03-31 | $879 |
| 2020-12-31 | $-1,122 |
| 2020-09-30 | $806 |
| 2020-06-30 | $620 |
| 2020-03-31 | $816 |
| 2019-12-31 | $888 |
| 2019-09-30 | $847 |
| 2019-06-30 | $909 |
| 2019-03-31 | $684 |
| 2018-12-31 | $227 |
| 2018-09-30 | $524 |
| 2018-06-30 | $561 |
| 2018-03-31 | $881 |
| 2017-12-31 | $-489 |
| 2017-09-30 | $845 |
| 2017-06-30 | $848 |
| 2017-03-31 | $734 |
| 2016-12-31 | $585 |
| 2016-09-30 | $767 |
| 2016-06-30 | $957 |
| 2016-03-31 | $877 |
| 2015-12-31 | $529 |
| 2015-09-30 | $969 |
| 2015-06-30 | $1,025 |
| 2015-03-31 | $911 |
| 2014-12-31 | $1,206 |
| 2014-09-30 | $1,164 |
| 2014-06-30 | $1,199 |
| 2014-03-31 | $1,054 |
| 2013-12-31 | $1,171 |
| 2013-09-30 | $1,015 |
| 2013-06-30 | $1,074 |
| 2013-03-31 | $947 |
| 2012-12-31 | $1,027 |
| 2012-09-30 | $954 |
| 2012-06-30 | $1,046 |
| 2012-03-31 | $886 |
| 2011-12-31 | $178 |
| 2011-09-30 | $170 |
| 2011-06-30 | $187 |
| 2011-03-31 | $159 |
| 2010-12-31 | $167 |
| 2010-09-30 | $132 |
| 2010-06-30 | $123 |
| 2010-03-31 | $120 |
| 2009-12-31 | $131 |
| 2009-09-30 | $129 |
| 2009-06-30 | $129 |
| 2009-03-31 | $136 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.875B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.366B | 20.52 |
| Inspire Medical Systems (INSP) | United States | $4.612B | 0.00 |
| Axonics (AXNX) | United States | $3.446B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.129B | 0.00 |
| 10x Genomics (TXG) | United States | $2.980B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.950B | 0.00 |
| Azenta (AZTA) | United States | $2.743B | 154.15 |
| Privia Health (PRVA) | United States | $2.016B | 112.67 |
| Schrodinger (SDGR) | United States | $1.654B | 0.00 |
| Omnicell (OMCL) | United States | $1.398B | 48.32 |
| Phreesia (PHR) | United States | $1.393B | 0.00 |
| Standard BioTools (LAB) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
| Talkspace (TALK) | United States | $0.467B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.442B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.349B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.191B | 0.00 |
| Outset Medical (OM) | United States | $0.187B | 0.00 |
| American Well (AMWL) | United States | $0.145B | 0.00 |
| TruBridge (TBRG) | United States | $0.134B | 7.19 |
| 111 (YI) | China | $0.111B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.107B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.064B | 0.00 |
| Augmedix (AUGX) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.042B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |